Product Images Tasigna
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Tasigna NDC 0078-0526 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical structure of nilotinib - tasigna 01
Figure 14-1 Kaplan-Meier estimate of treatment-free survival after start of TFR (Full Analysis Set ENESTfreedom) - tasigna 02
Figure 14-2 Kaplan-Meier estimate of treatment-free survival after start of TFR (Full Analysis Set ENESTop) - tasigna 03
The text appears to be a chart representing Treatment free survival over time, with percentage values indicated in the leftmost column and time since TFR (in weeks) in the top row. The chart also includes some additional text and symbols that are not clearly readable.*
NDC 0078-0592-87Tasigna(nilotinib) capsules150 mg - tasigna 04
NDC 0078-0526-87Tasigna(nilotinib) capsules200 mg - tasigna 05
This is a medical description of Tasigna (nilotinib) capsules, containing 200mg per capsule. The drug is for oral use and comes in a blister pack of 28 capsules. The recommended storage temperature is between 20°C to 25°C, and the medication guide should be attached or provided separately. For more information, visit the USTASIGNA website or consult the prescribing information.*
NDC 0078-0951-8766Tasigna(nilotinib) capsules50 mg - tasigna 06
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.